Markets:

Overview

News

Currencies

International

Treasuries

Omnicell, Inc. - Common Stock (NQ:OMCL)

36.08 -1.22 (-3.28%)

Streaming Delayed Price Updated: 12:09 PM EDT, Aug 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Omnicell, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session ↗

November 02, 2022

Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results.

Via Benzinga

Rogers, Airbnb, Herbalife And Some Other Big Stocks Moving Lower On Wednesday ↗

November 02, 2022

U.S. stocks traded lower, with the Nasdaq Composite dropping more than 100 points on Wednesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

What 4 Analyst Ratings Have To Say About Omnicell ↗

September 09, 2022

Within the last quarter, Omnicell (NASDAQ:OMCL) has observed the following analyst ratings:

Via Benzinga

Omnicell: Q3 Earnings Insights ↗

November 02, 2022

Omnicell (NASDAQ:OMCL) reported its Q3 earnings results on Wednesday, November 2, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Omnicell beat estimated earnings...

Via Benzinga

Omnicell Announces Financial Results for Third Quarter 2022

November 02, 2022

From Omnicell, Inc.

Via Business Wire

Omnicell to Release Third Quarter 2022 Financial Results on November 2, 2022

October 13, 2022

From Omnicell, Inc.

Via Business Wire

Omnicell Launches Specialty Pharmacy Services to Support Optimized Outpatient Medication Management and Drive Clinical and Business Outcomes for Health Systems

October 11, 2022

From Omnicell, Inc.

Via Business Wire

Expert Ratings for Omnicell ↗

July 27, 2022

Omnicell (NASDAQ:OMCL) has observed the following analyst ratings within the last quarter:

Via Benzinga

Omnicell's Q4 Earnings In Line With Expectations, Issues Mixed FY22 Guidance ↗

February 15, 2022

Omnicell Inc's (NASDAQ: OMCL)

Via Benzinga

Spero Therapeutics To Rally Around 240%? Plus This Analyst Slashes PT On Salesforce ↗

September 23, 2022

Evercore ISI Group raised the price target on Spero Therapeutics, Inc. (NASDAQ: SPRO) from $2 to $8. Evercore ISI Group analyst Josh Schimmer also upgraded the stock from In-Line to Outperform. Spero...

Via Benzinga

Morgan Stanley To Rally Over 10%? Here Are 5 Other Price Target Changes For Wednesday ↗

September 21, 2022

Credit Suisse raised the price target on Morgan Stanley (NYSE: MS) from $95 to $97. Credit Suisse analyst Susan Roth Katzke maintained the stock with an Outperform rating. Morgan Stanley shares rose...

Via Benzinga

Omnicell Highlights Differentiated Strategy and Unique Business Model at 2022 Investor Day

September 20, 2022

From Omnicell, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022 ↗

September 16, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022 ↗

September 09, 2022

Upgrades

Via Benzinga

Omnicell to Present at the 2022 Wells Fargo Healthcare Conference

August 31, 2022

From Omnicell, Inc.

Via Business Wire

Omnicell to Host Investor Day on September 20, 2022

August 25, 2022

From Omnicell, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

August 05, 2022

On Friday, 72 companies set new 52-week lows.

Via Benzinga

Recap: Omnicell Q2 Earnings ↗

August 04, 2022

Omnicell (NASDAQ:OMCL) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Omnicell missed estimated earnings...

Via Benzinga

Omnicell Announces Financial Results for Second Quarter 2022

August 04, 2022

From Omnicell, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022 ↗

July 15, 2022

Via Benzinga

Omnicell to Release Second Quarter 2022 Financial Results on August 4, 2022

July 11, 2022

From Omnicell, Inc.

Via Business Wire

Omnicell Announces Financial Results for First Quarter 2022

April 28, 2022

From Omnicell, Inc.

Via Business Wire

Omnicell to Release First Quarter 2022 Financial Results on April 28, 2022

April 05, 2022

From Omnicell, Inc.

Via Business Wire

Omnicell Unveils Innovative IVX Station Robotic Compounding Technology in Winter 2022 Release

March 29, 2022

From Omnicell, Inc.

Via Business Wire

7 Top Mutual Funds to Buy to Keep Taxes Low ↗

March 02, 2022

Mutual funds can be excellent investments because they provide diversification, liquidity, and professional management at a low cost.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Tuesday ↗

February 15, 2022

Tuesday's session saw 95 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-...

Via Benzinga

Recap: Omnicell Q4 Earnings ↗

February 14, 2022

Omnicell (NASDAQ:OMCL) reported its Q4 earnings results on Monday, February 14, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Omnicell reported in-line EPS of...

Via Benzinga

UMC Health System Partners with Omnicell for Advanced Services Solutions to Streamline Medication Management and Enhance Clinical and Operational Outcomes

February 14, 2022

From Omnicell, Inc.

Via Business Wire

Omnicell Reports Fiscal Year and Fourth Quarter 2021 Results

February 14, 2022

From Omnicell, Inc.

Via Business Wire

Earnings Scheduled For February 14, 2022 ↗

February 14, 2022

Companies Reporting Before The Bell • Weber (NYSE:WEBR) is projected to report quarterly loss at $0.06 per share on revenue of $310.78 million.

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.